跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lexdin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lexdin
Approved
STANDARD
Lexdin
Sydenham Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f6ecd58e2deef392
Company
Sydenham Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
f6ecd58e2deef392
Drug Approval Philippines Name
Lexdin
Product Name
Lexdin
Registration Number
DRP-7781
Brand Name
Lexdin
Generic Name
Escitalopram (As Oxalate)
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Sydenham Laboratories, Inc.
Trader
Medchoice CNS Pharma Corporation
Issuance Date
26 October 2022
Expiry Date
26 October 2027
Pharmacologic Category
Antidepressant (Selective Serotonin Reuptake Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f6ecd58e2deef392
Type
Standard
Back to Philippines FDA Approvals